Commercial Opportunity or Addressing Unmet Needs—Loop-Mediated Isothermal Amplification (LAMP) as the Future of Rapid Diagnostic Testing?
Abstract
:1. Introduction
2. Materials and Methods
2.1. Data Collection and Curation
2.2. Data Analysis
3. Results
3.1. Life Cycle Phase
3.2. Patent Jurisdiction
3.3. Patent Applicants
3.4. Clinical Trials
3.5. Patent Claims
3.6. Cooperative Patent Classifications
4. Discussion
5. Implications and Further Research
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gardy, J.L.; Loman, N.J. Towards a genomics-informed, real-time, global pathogen surveillance system. Nat. Rev. Genet. 2018, 19, 9–20. [Google Scholar] [CrossRef] [PubMed]
- Teymouri, M.; Mollazadeh, S.; Mortazavi, H.; Ghale-Noie, Z.N.; Keyvani, V.; Aghababaei, F.; Hamblin, M.R.; Abbaszadeh-Goudarzi, G.; Pourghadamyari, H.; Hashemian, S.M.R. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathol. Res. Pract. 2021, 221, 153443. [Google Scholar] [CrossRef]
- Oliveira, B.B.; Veigas, B.; Baptista, P.V. Isothermal amplification of nucleic acids: The race for the next “gold standard”. Front. Sens. 2021, 2, 752600. [Google Scholar] [CrossRef]
- Soroka, M.; Wasowicz, B.; Rymaszewska, A. Loop-mediated isothermal amplification (LAMP): The better sibling of PCR? Cells 2021, 10, 1931. [Google Scholar] [CrossRef]
- Notomi, T.; Okayama, H.; Masubuchi, H.; Yonekawa, T.; Watanabe, K.; Amino, N.; Hase, T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000, 28, e63. [Google Scholar] [CrossRef] [PubMed]
- Inaba, M.; Higashimoto, Y.; Toyama, Y.; Horiguchi, T.; Hibino, M.; Iwata, M.; Imaizumi, K.; Doi, Y. Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection. Int. J. Infect. Dis. 2021, 107, 195–200. [Google Scholar] [CrossRef]
- Schellenberg, J.J.; Ormond, M.; Keynan, Y. Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples. J. Clin. Virol. 2021, 136, 104764. [Google Scholar] [CrossRef]
- Dong, Y.; Wu, X.; Li, S.; Lu, R.; Li, Y.; Wan, Z.; Qin, J.; Yu, G.; Jin, X.; Zhang, C. Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2. Sci. Rep. 2021, 11, 2936. [Google Scholar] [CrossRef]
- Velders, A.H.; Ossendrijver, M.; Keijser, B.J.; Saggiomo, V. T-Cup: A Cheap, Rapid, and Simple Home Device for Isothermal Nucleic Acid Amplification. Glob. Chall. 2022, 6, 2100078. [Google Scholar] [CrossRef]
- Kubota, R.; Labarre, P.; Weigl, B.H.; Li, Y.; Haydock, P.; Jenkins, D.M. Molecular diagnostics in a teacup: Non-Instrumented Nucleic Acid Amplification (NINA) for rapid, low cost detection of Salmonella enterica. Chin. Sci. Bull. 2013, 58, 1162–1168. [Google Scholar] [CrossRef]
- Singleton, J.; Osborn, J.L.; Lillis, L.; Hawkins, K.; Guelig, D.; Price, W.; Johns, R.; Ebels, K.; Boyle, D.; Weigl, B.; et al. Electricity-free amplification and detection for molecular point-of-care diagnosis of HIV-1. PLoS ONE 2014, 9, e113693. [Google Scholar] [CrossRef] [PubMed]
- Bharadwaj, M.; Bengtson, M.; Golverdingen, M.; Waling, L.; Dekker, C. Diagnosing point-of-care diagnostics for neglected tropical diseases. PLoS Neglected Trop. Dis. 2021, 15, e0009405. [Google Scholar] [CrossRef]
- Jelle, J.F.; Eric, C. Addressing the unmet need in respiratory viruses: An interdisciplinary analysis of product development pipeline in Asia. Int. J. Clin. Trials 2018, 5, 151. [Google Scholar]
- Behnam, M.; Dey, A.; Gambell, T.; Talwar, V. COVID-19: Overcoming Supply Shortages for Diagnostic Testing; McKinsey & Company: Chicago, IL, USA, 2020; Volume 8. [Google Scholar]
- Moehling, T.J.; Choi, G.; Dugan, L.C.; Salit, M.; Meagher, R.J. LAMP diagnostics at the point-of-care: Emerging trends and perspectives for the developer community. Expert Rev. Mol. Diagn. 2021, 21, 43–61. [Google Scholar] [CrossRef]
- van der Waal, M.B.; Feddema, J.J.; van de Burgwal, L.H. Mapping the broad societal impact of patents. Technovation 2023, 128, 102876. [Google Scholar] [CrossRef]
- Ramezanpour, B.; Haan, I.; Osterhaus, A.; Claassen, E. Vector-based genetically modified vaccines: Exploiting Jenner’s legacy. Vaccine 2016, 34, 6436–6448. [Google Scholar] [CrossRef]
- Office EP. 2024. Available online: https://worldwide.espacenet.com/ (accessed on 8 January 2023).
- Yang, S. Ending Patent Subsidies in China. 2022. Available online: https://www.mondaq.com/china/patent/1150552/ending-patent-subsidies-in-china (accessed on 14 February 2023).
- Neevel, A.M.; Urias, E.; Claassen, E.; van De Burgwal, L.H. Quantity vs. quality: An assessment of the current pipeline for rabies. Trop. Med. Int. Health 2020, 25, 397–407. [Google Scholar] [CrossRef]
- WHO. ICTRP Search Portal. 2024. Available online: https://www.who.int/clinical-trials-registry-platform/the-ictrp-search-portal (accessed on 24 May 2023).
- NIH. 2024. Available online: https://clinicaltrials.gov/ (accessed on 24 May 2023).
- Chen, Y.-H.; Chen, C.-Y.; Lee, S.-C. Technology forecasting and patent strategy of hydrogen energy and fuel cell technologies. Int. J. Hydrogen Energy 2011, 36, 6957–6969. [Google Scholar] [CrossRef]
- Ernst, H. The use of patent data for technological forecasting: The diffusion of CNC-technology in the machine tool industry. Small Bus. Econ. 1997, 9, 361–381. [Google Scholar] [CrossRef]
- Weenen, T.C.; Fernald, K.; Pronker, E.S.; Commandeur, H.; Claassen, E. Bridging a pharma-like innovation gap in medical nutrition. In Pharma-Nutrition: An Overview; Springer: Cham, Switzerland, 2014; pp. 29–52. [Google Scholar]
- Fernald, K.; Hoeben, R.; Claassen, E. Venture capitalists as gatekeepers for biotechnological innovation. J. Commer. Biotechnol. 2015, 21, 32–41. [Google Scholar] [CrossRef]
- Gao, L.; Porter, A.L.; Wang, J.; Fang, S.; Zhang, X.; Ma, T.; Wang, W.; Huang, L. Technology life cycle analysis method based on patent documents. Technol. Forecast. Soc. Change 2013, 80, 398–407. [Google Scholar] [CrossRef]
- Mushtaq, M.; Ahmad Dar, A.; Skalicky, M.; Tyagi, A.; Bhagat, N.; Basu, U.; Bhat, B.A.; Zaid, A.; Ali, S.; Dar, T.-U.-H. CRISPR-based genome editing tools: Insights into technological breakthroughs and future challenges. Genes 2021, 12, 797. [Google Scholar] [CrossRef]
- Selvam, K.; Najib, M.A.; Khalid, M.F.; Mohamad, S.; Palaz, F.; Ozsoz, M.; Aziah, I. RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods. Diagnostics 2021, 11, 1646. [Google Scholar] [CrossRef] [PubMed]
- Atçeken, N.; Yigci, D.; Ozdalgic, B.; Tasoglu, S. CRISPR-Cas-Integrated LAMP. Biosensors 2022, 12, 1035. [Google Scholar] [CrossRef] [PubMed]
- Obande, G.A.; Banga Singh, K.K. Current and future perspectives on isothermal nucleic acid amplification technologies for diagnosing infections. Infect. Drug Resist. 2020, 13, 455–483. [Google Scholar] [CrossRef]
- Dramé, M.; Teguo, M.T.; Proye, E.; Hequet, F.; Hentzien, M.; Kanagaratnam, L.; Godaert, L. Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? J. Med. Virol. 2020, 92, 2312–2313. [Google Scholar] [CrossRef]
- Hernández-Huerta, M.T.; Pérez-Campos Mayoral, L.; Sanchez Navarro, L.M.; Mayoral-Andrade, G.; Pérez-Campos Mayoral, E.; Zenteno, E.; Pérez-Campos, E. Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? J. Med. Virol. 2021, 93, 137–138. [Google Scholar] [CrossRef]
- Notomi, T.; Mori, Y.; Tomita, N.; Kanda, H. Loop-mediated isothermal amplification (LAMP): Principle, features, and future prospects. J. Microbiol. 2015, 53, 1–5. [Google Scholar] [CrossRef]
- Augustine, R.; Hasan, A.; Das, S.; Ahmed, R.; Mori, Y.; Notomi, T.; Kevadiya, B.D.; Thakor, A.S. Loop-mediated isothermal amplification (LAMP): A rapid, sensitive, specific, and cost-effective point-of-care test for coronaviruses in the context of COVID-19 pandemic. Biology 2020, 9, 182. [Google Scholar] [CrossRef]
- Reboud, J.; Xu, G.; Garrett, A.; Adriko, M.; Yang, Z.; Tukahebwa, E.M.; Rowell, C.; Cooper, J.M. based microfluidics for DNA diagnostics of malaria in low resource underserved rural communities. Proc. Natl. Acad. Sci. USA 2019, 116, 4834–4842. [Google Scholar] [CrossRef]
- García-Bernalt Diego, J.; Fernandez-Soto, P.; Muro, A. LAMP in neglected tropical diseases: A focus on parasites. Diagnostics 2021, 11, 521. [Google Scholar] [CrossRef] [PubMed]
- Cooke, P. New economy innovation systems: Biotechnology in Europe and the USA. Ind. Innov. 2001, 8, 267–289. [Google Scholar] [CrossRef]
- Dosi, G.; Llerena, P.; Labini, M.S. The relationships between science, technologies and their industrial exploitation: An illustration through the myths and realities of the so-called ‘European Paradox’. Res. Policy 2006, 35, 1450–1464. [Google Scholar] [CrossRef]
- Nicholls, A.; Edmiston, D. Social innovation policy in the European Union. In Policy Design in the European Union: An Empire of Shopkeepers in the Making? Palgrave Macmillan: Cham, Switzerland, 2018; pp. 161–190. [Google Scholar]
- Massey, A.; Johnston-Miller, K. Governance: Public governance to social innovation? Policy Politics 2016, 44, 663–675. [Google Scholar] [CrossRef]
- Innovation D-GfRa. Horizon 2020. 2024. Available online: https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-2020_en (accessed on 24 May 2023).
- Van de Burgwal, L.H.; Reperant, L.A.; Osterhaus, A.D.; Iancu, S.C.; Pronker, E.S.; Claassen, E. Self-centric and altruistic unmet needs for ebola: Barriers to international preparedness. Disaster Med. Public Health Prep. 2016, 10, 644–648. [Google Scholar] [CrossRef]
- Defourny, J.; Nyssens, M. Conceptions of social enterprise and social entrepreneurship in Europe and the United States: Convergences and divergences. J. Soc. Entrep. 2010, 1, 32–53. [Google Scholar] [CrossRef]
- Drain, P.K.; Hyle, E.P.; Noubary, F.; Freedberg, K.A.; Wilson, D.; Bishai, W.R.; Rodriguez, W.; Bassett, I.V. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect. Dis. 2014, 14, 239–249. [Google Scholar] [CrossRef]
- Jani, I.V.; Peter, T.F. Nucleic acid point-of-care testing to improve diagnostic preparedness. Clin. Infect. Dis. 2022, 75, 723–728. [Google Scholar] [CrossRef]
- Rethinking diagnostics for pandemic readiness. Nat. Biomed. Eng. 2022, 6, 221–222. [CrossRef]
- Miller, E.; Sikes, H.D. Addressing barriers to the development and adoption of rapid diagnostic tests in global health. Nanobiomedicine 2015, 2, 2–6. [Google Scholar] [CrossRef]
- Franck, L.S.; Kriz, R.M.; Rego, S.; Garman, K.; Hobbs, C.; Dimmock, D. Implementing rapid whole-genome sequencing in critical care: A qualitative study of facilitators and barriers to new technology adoption. J. Pediatr. 2021, 237, 237–243. [Google Scholar] [CrossRef] [PubMed]
- Llewellyn, S.; Procter, R.; Harvey, G.; Maniatopoulos, G.; Boyd, A. Facilitating Technology Adoption in the NHS: Negotiating the Organisational and Policy Context—A Qualitative Study; NIHR Journals Library: Southampton, UK, 2015. [Google Scholar]
Company (Industry) | Number of Patents | Year of First Patent | University/Research Institution | Number of Patents | Year of First Patent |
---|---|---|---|---|---|
Toshiba | 24 | 2007 | Broad Inst Inc | 19 | 2015 |
Eiken Chemical | 17 | 2006 | Massachusetts Inst Technology | 19 | 2015 |
New england Biolabs | 13 | 2013 | Harvard College | 18 | 2014 |
Alveo Tech | 11 | 2017 | California Inst of Techn | 16 | 2014 |
Becton Dickinson | 10 | 2011 | Univ California | 15 | 2011 |
Raytheon Technologies | 10 | 2022 | Univ Sungkyunkwan Res & Bus | 15 | 2013 |
Mammoth Biosciences | 9 | 2020 | Purdue Research Foundation | 12 | 2022 |
Qiagen | 9 | 2003 | Univ Arizona State | 9 | 2017 |
Sysmex | 9 | 2004 | Univ Texas | 9 | 2003 |
Genomtec | 7 | 2021 | Korea Advanced Institute of Science and Tech | 7 | 2018 |
Nippon | 7 | 2011 | Kyungpook Nat Univ Ind Acad | 7 | 2014 |
Talis Biomedical | 7 | 2018 | Nat Inst Forest Science | 7 | 2017 |
3M Innovative Properties | 6 | 2016 | Nat Univ Chungbuk Ind Acad Coop Found | 7 | 2018 |
Capitalbio | 6 | 2012 | Univ Dankook Cheonan Campus Ind Academic Cooperation Foundation | 7 | 2017 |
Mmonitor | 6 | 2016 | Univ Washington | 7 | 2012 |
Speedx | 6 | 2007 | Univ Chung Ang Ind | 6 | 2011 |
Dnaform | 5 | 2006 | Univ Hallym Iacf | 6 | 2014 |
Moth Diagnostics | 5 | 2021 | Univ Pennsylvania | 6 | 2012 |
Nanostring Technologies | 5 | 2017 | Univ Tsinghua | 6 | 2012 |
Singlera Genomics | 5 | 2018 | Univ Korea Res & Bus Found | 5 | 2020 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Feddema, J.J.; Fernald, K.D.S.; Keijser, B.J.F.; Kieboom, J.; van de Burgwal, L.H.M. Commercial Opportunity or Addressing Unmet Needs—Loop-Mediated Isothermal Amplification (LAMP) as the Future of Rapid Diagnostic Testing? Diagnostics 2024, 14, 1845. https://doi.org/10.3390/diagnostics14171845
Feddema JJ, Fernald KDS, Keijser BJF, Kieboom J, van de Burgwal LHM. Commercial Opportunity or Addressing Unmet Needs—Loop-Mediated Isothermal Amplification (LAMP) as the Future of Rapid Diagnostic Testing? Diagnostics. 2024; 14(17):1845. https://doi.org/10.3390/diagnostics14171845
Chicago/Turabian StyleFeddema, Jelle J., Kenneth D. S. Fernald, Bart J. F. Keijser, Jasper Kieboom, and Linda H. M. van de Burgwal. 2024. "Commercial Opportunity or Addressing Unmet Needs—Loop-Mediated Isothermal Amplification (LAMP) as the Future of Rapid Diagnostic Testing?" Diagnostics 14, no. 17: 1845. https://doi.org/10.3390/diagnostics14171845